Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2 clinical trials · Condition
◉ Watch Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor (NCT03041181) | Nasser Hanna, M.D. | 2017-01-27 |
Track Non-Squamous Non-Small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.